Last night’s program was held at the legendary Delmonico’s located in the Financial District. The topic of discussion was “A Breakthrough in Cardiovascular Outcomes”. Our speaker of the night was Adam Rosenbluth, MD.
We also had a Clinical Pearl from St. John’s 2019 Pharm.D. candidate Joseph Eskandrous. His topic of discussion was “Inhaled Isopropyl Alcohol versus Oral Ondansetron for Antiemetic Therapy Among Adult ED Patients”.
Thank you to Boeringher-Ingelheim for sponsoring this program. More pictures on Instagram. Follow us @officialnycshp
Photos and editing by Dominique Maurice, Pharm.D.